Search for: "Novartis Corporation" Results 101 - 120 of 312
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
15 May 2018, 9:01 pm by Michael C. Dorf
Read for all it is worth, Dodge would not only permit, but require AT&T, Novartis, and other corporations to pursue opportunities of the sort presented by Cohen if they concluded that paying Cohen was legal and that, all things considered, doing so would maximize corporate profits.However, Dodge has rarely been read for all it is worth. [read post]
15 May 2018, 11:59 am by JAY HANCOCK, KAISER HEALTH NEWS
Hiring the president’s personal attorney matches a history of aggressively courting government officials by a corporation with much to lose in the debate over high drug prices. [read post]
15 Oct 2008, 8:38 am
"In effect the Bush administration made the safety of Americans secondary to corporate profits. [read post]
21 Oct 2007, 12:55 pm
On March 30, 2007, the FDA requested that Novartis Pharmaceuticals Corporation ("Novartis"), the manufacturer of Zelnorm, voluntarily remove the drug from the market. [read post]
5 Oct 2010, 1:56 am by sally
High Court (Queen’s Bench Division) Gray v Crown Prosecution Service [2010] EWHC 2144 (QB) (20 August 2010) High Court (Chancery Division) British Broadcasting Corporation v Harpercollins Publishers Ltd & Anor [2010] EWHC 2424 (Ch) (04 October 2010) High Court (Administrative Court) Hulme, R (on the application of) v Secretary of State for Communities & Local Government [2010] EWHC 2386 (Admin) (19 August 2010) Crown Prosecution Service, R (on the application of) v Kumbaro… [read post]
21 Sep 2020, 12:41 pm by Rebecca Tushnet
Finally, Diamond tried to get the court to adopt the rule of Novartis Consumer Health, Inc. v. [read post]
15 Dec 2020, 9:53 am by Dennis Crouch
Novartis Pharmaceuticals Corporation (Supreme Court 2020) Introducing generic alternatives that compete with previously approved drugs requires market approval through the Food and Drug Administration (“FDA”). [read post]
30 Aug 2009, 10:00 pm
Bivins (a citizen of Texas) sued Novartis Pharmaceuticals (a Delaware corporation with its principal place of business in New Jersey), Novartis Pharma GmbH (a German corporation), and Novartis AG (a Swiss corporation) in New Jersey state court. [read post]
3 Sep 2010, 9:43 am by Greenberg & Bederman
Some large corporations have a tendency to behave with ignorance when it comes to the internet. [read post]
21 Nov 2017, 2:40 pm by Tom Lamb
We recommend that the FDA and [Novartis Pharmaceuticals Corporation] the manufacturer [of Entresto] more clearly communicate the full risk of hypotension, including appropriate steps for monitoring patients, and examine whether a more gradual escalation of dose to the recommended level would reduce the risk. [read post]
5 May 2010, 5:14 pm by FDABlog HPM
Martin – FDA just released the Warning Letter it issued to Novartis Pharmaceuticals Corporation (“Novartis”) in April regarding two purportedly unbranded websites, www.gistalliance.com and www.cmlalliance.com (the “alliance websites”), which included disease-state information and clinical data about gastrointestinal stromal tumors (“GIST”) and chronic myeloid leukemia (“CML”). [read post]
28 Oct 2010, 8:21 am by Andrew Goldberg
  Much of the patent news that was published on this blog has been moved to the IP Insider section of the Corporate Counsel website. [read post]
30 Oct 2009, 3:35 am
., Vol. 1, Nov. 2009 at 70, describes several aspects of the 100-lawyer department of Computer Sciences Corporation (CSC), primarily those related to its current strategic plan (See my post of June 25, 2008: strategic plan with 10 references.). [read post]
2 Nov 2015, 2:05 pm by Michael Rosenblat
  (See, Blog post DOJ to Focus on Individual Accountability for Corporate Fraud.) [read post]
29 Mar 2012, 10:00 pm by Stephanie Figueroa
Life Technologies Corporation et al.,  and how, “this case provides a good reminder to corporate IP counsel to carefully review all tech transfer agreements during mergers or reorganizations. [read post]
29 Mar 2012, 10:00 pm by Stephanie Figueroa
Life Technologies Corporation et al.,  and how, “this case provides a good reminder to corporate IP counsel to carefully review all tech transfer agreements during mergers or reorganizations. [read post]
27 Sep 2010, 12:59 am by FDABlog HPM
Karst –    Just two days after Novartis Pharmaceuticals Corporation (“Novartis”) filed a Complaint in the U.S. [read post]